A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Triple Negative Breast Cancer · Breast Cancer · Endometrial Cancer · Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cavity Cancer · Adenoid Cystic Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona, United States

    Contact: Study coordinator (Felipe Batalini, MD)
    Contact: Principal Investigator (Felipe Batalini, MD)
  • UC Irvine Health-Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Ritesh Parajuli)
    Contact: Principal Investigator (Ritesh Parajuli)
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

    Contact: Study coordinator (Laura Huppert, MD)
    Contact: Principal Investigator (Laura Huppert, MD)
  • UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica, California, United States

    Contact: Study coordinator (Nicholas McAndrew, MD)
    Contact: Principal Investigator (Nicholas McAndrew, MD)
  • Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

    Contact: Study coordinator (Pooja Advani, MD)
    Contact: Principal Investigator (Pooja Advani, MD)
  • Florida Cancer Specialists, Sarasota, Florida, United States

    Contact: Study coordinator (Judy Wang)
    Contact: Principal Investigator (Judy Wang)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Hyo Han, MD)
    Contact: Principal Investigator (Hyo Han, MD)
  • Winship Cancer Institute, Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Kevin Kalinsky, MD)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Patricia Robinson, MD)
    Contact: Principal Investigator (Patricia Robinson, MD)
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Gerburg Wulf, MD)
    Contact: Principal Investigator (Gerburg Wulf, MD)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Antonio Giordano, MD, PhD)
  • Henry Ford Health Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Amy Weise, MD)
  • Mayo Clinic - Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Roberto Leon-Ferre, MD)
    Contact: Principal Investigator (Roberto Leon-Ferre, MD)
  • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Liawaty Ho, MD)
    Contact: Principal Investigator (Liawaty Ho, MD)
  • New York University Langone Health, New York, New York, United States

    Contact: Study coordinator (Nancy Chan, MD)
  • ICHAN School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Amy Tiersten)
    Contact: Principal Investigator (Amy Tiersten)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Nour Abuhadra, MD)
  • Stephenson Cancer Center Oklahoma University Health, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Debra Richardson, MD)
    Contact: Principal Investigator (Debra Richardson, MD)
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (David C. Starks, MD)
    Contact: Principal Investigator (David C. Starks, MD)
  • Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States

    Contact: Study coordinator (Erika P Hamilton, MD)
  • Texas Oncology, P.A., Dallas, Texas, United States

    Contact: Principal Investigator (Joyce O'Shaughnessy, MD)
  • MD Anderson, Houston, Texas, United States

    Contact: Study coordinator (Funda Meric-Bernstam)
    Contact: Principal Investigator (Funda Meric-Bernstam)
  • Huntsman Cancer Institute, Salt Lake City, Utah, United States

    Contact: Study coordinator (Kristen Kelley, MD)
    Contact: Principal Investigator (Kristen Kelley, MD)
  • NEXT Oncology Virginia, Fairfax, Virginia, United States

    Contact: Study coordinator (Alex Spira, MD, PhD)
  • Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Jennifer Specht, MD)
  • Summit Cancer Centers, Spokane, Washington, United States

    Contact: Study coordinator (Arvind Chaudhry, MD, PhD)
מובילי המחקר
  • Robert Burger, MD

    Study Director

    Day One Biopharmaceuticals, Inc.